Saba Capital Management, L.P., a significant stakeholder in BlackRock (NYSE:) Capital Allocation Term Trust (NYSE:), reported the sale of 5,204 shares of the trust’s common stock. The shares were sold at a price of $15.76 each, totaling approximately $82,015. The transaction price was close to BCAT’s current trading level of $15.69, with the stock trading near its 52-week low of $15.00. Following this transaction, Saba Capital holds 13,612,073 shares indirectly in the $1.69 billion market cap trust, which notably offers a substantial 22.07% dividend yield. InvestingPro analysis reveals several additional insights about BCAT’s performance and valuation metrics. The transaction was disclosed in a recent SEC filing dated January 23, 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
